143 related articles for article (PubMed ID: 17674458)
1. A national survey of physician-industry relationships.
Grande D
N Engl J Med; 2007 Aug; 357(5):507-8; author reply 508. PubMed ID: 17674458
[No Abstract] [Full Text] [Related]
2. A national survey of physician-industry relationships.
Gorske AL
N Engl J Med; 2007 Aug; 357(5):508; author reply 508. PubMed ID: 17674457
[No Abstract] [Full Text] [Related]
3. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
4. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
5. Physician interaction with pharmaceutical companies: the rules are getting tougher.
Loomis CH
J Okla State Med Assoc; 2003 Jun; 96(6):278-9. PubMed ID: 12858819
[No Abstract] [Full Text] [Related]
6. Industry-physician relationships: a call for greater distance. Catholic health care systems need to join others in adopting stricter guidelines.
Panicola MR; Hamel R
Health Prog; 2009; 90(4):62-8. PubMed ID: 19603723
[No Abstract] [Full Text] [Related]
7. Physician-industry interactions: there is no such thing as a free lunch.
Tsai HJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
[No Abstract] [Full Text] [Related]
8. The new relationship between physicians & industry.
Van Way CW
Mo Med; 2007; 104(5):375-7. PubMed ID: 18018517
[No Abstract] [Full Text] [Related]
9. WMA sets rules on how doctors handle industry sponsorship.
Kmietowicz Z
BMJ; 2004 Oct; 329(7471):876. PubMed ID: 15485951
[No Abstract] [Full Text] [Related]
10. A review of the federal guidelines that inform and influence relationships between physicians and industry.
Birkhahn RH; Jauch E; Kramer DA; Nowak RM; Raja AS; Summers RL; Weber JE; Diercks DB;
Acad Emerg Med; 2009 Aug; 16(8):776-81. PubMed ID: 19594459
[TBL] [Abstract][Full Text] [Related]
11. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
Quan SF
J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
[No Abstract] [Full Text] [Related]
12. Restrictions on business relationships with industries, and their unintended adverse consequences.
Sataloff RT
Ear Nose Throat J; 2009 May; 88(5):904-8. PubMed ID: 19444783
[No Abstract] [Full Text] [Related]
13. Drug company influence.
Mittman D
Am J Nurs; 2009 Mar; 109(3):14; author reply 14. PubMed ID: 19240469
[No Abstract] [Full Text] [Related]
14. Put your office in the driver's seat. Eight steps to streamline sales rep support.
Messerly W; Ruoff K
MGMA Connex; 2007 Aug; 7(7):27-8. PubMed ID: 17803099
[No Abstract] [Full Text] [Related]
15. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
Blehart B
J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
[No Abstract] [Full Text] [Related]
16. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Schetky DH
Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
[TBL] [Abstract][Full Text] [Related]
17. Sponsorships for medical specialists.
Magotra R
Issues Med Ethics; 1997; 5(4):122-5. PubMed ID: 16267917
[No Abstract] [Full Text] [Related]
18. [The influence of the pharmaceutical industry on treatment guidelines].
Kramers C; Wuis E; Schouwenberg B
Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
[No Abstract] [Full Text] [Related]
19. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
20. Factors associated with physicians' reliance on pharmaceutical sales representatives.
Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
